DocGo Inc. 8-K Summary: Nasdaq Delisting Notice
Business Context and Reporting Period
DocGo Inc. (DCGO), a Delaware corporation, filed this Form 8-K on January 26, 2026. The filing addresses a regulatory notice received from The Nasdaq Stock Market LLC regarding the company's compliance with listing standards.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, or debt metrics. The only financial data point provided is the stock price performance triggering the notice:
- Stock Price Deficiency: The closing bid price of Common Stock was below $1.00 per share for the period from December 9, 2025, to January 23, 2026.
- Listing Status: The stock remains listed on The Nasdaq Capital Market as of the filing date.
Material Changes
The material event is the receipt of a formal Notice from Nasdaq stating the Company is not in compliance with Listing Rule 5550(a)(2) (Minimum Bid Requirement). This is a change in regulatory status rather than a change in operational financials.
Outlook, Management Commentary, and Risks
Compliance Timeline: The Company has 180 calendar days (until July 27, 2026) to regain compliance. To do so, the closing bid price must meet or exceed $1.00 per share for ten consecutive business days prior to the deadline.
Contingency Plans: If the Company fails to regain compliance by July 27, 2026, it may be eligible for a second 180-day compliance period. Qualification for this extension requires meeting all other initial listing standards (excluding the bid price) and notifying Nasdaq of intent to cure, which may include effecting a reverse stock split.
Risks: There is no assurance the Company will regain compliance, secure a second period, or avoid delisting. If delisting is imminent, the Company retains the right to appeal to a Nasdaq hearings panel.
Investor Verification Checklist
- Verify the current closing bid price of DCGO to assess proximity to the $1.00 threshold.
- Monitor for announcements regarding a potential reverse stock split to cure the deficiency.
- Check for any subsequent Nasdaq communications regarding the approval or denial of a second compliance period.
- Review the company's market value of publicly held shares to ensure it meets other Nasdaq Capital Market listing standards.